NIM
NEOS Investment Management Portfolio holdings
AUM
$8.08B
1-Year Return
24.46%
This Quarter Return
+16.38%
1 Year Return
+24.46%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$8.08B
AUM Growth
+$2.81B
(+53%)
Cap. Flow
+$2.18B
Cap. Flow
% of AUM
26.98%
Top 10 Holdings %
Top 10 Hldgs %
37.62%
Holding
626
New
29
Increased
519
Reduced
46
Closed
10
Top Buys
| 1 |
NVIDIA
NVDA
|
$166M |
| 2 |
Microsoft
MSFT
|
$162M |
| 3 |
Apple
AAPL
|
$126M |
| 4 |
Broadcom
AVGO
|
$86.4M |
| 5 |
Amazon
AMZN
|
$85.6M |
Top Sells
| 1 |
Clean Harbors
CLH
|
$4.34M |
| 2 |
Rockwell Automation
ROK
|
$4.29M |
| 3 |
Vulcan Materials
VMC
|
$4.24M |
| 4 |
Applied Industrial Technologies
AIT
|
$3.95M |
| 5 |
ATI
ATI
|
$3.93M |
Sector Composition
| 1 | Technology | 37.54% |
| 2 | Communication Services | 11.03% |
| 3 | Consumer Discretionary | 10.09% |
| 4 | Healthcare | 8.06% |
| 5 | Financials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
Gaming and Leisure Properties
GLPI
$13.6B
| $609K | 0.01% |
13,049
+7,143
| +121% | +$333K |
|
527
Franklin Resources
BEN
$13.3B
| $596K | 0.01% |
24,997
+5,349
| +27% | +$128K |
|
528
Guardant Health
GH
$7.42B
| $591K | 0.01% |
11,350
+1,190
| +12% | +$61.9K |
|
529
Icon
ICLR
$13.3B
| $576K | 0.01% |
+3,959
| New | +$576K |
|
530
Jones Lang LaSalle
JLL
$14.4B
| $575K | 0.01% |
2,247
+1,225
| +120% | +$313K |
|
531
Equity Lifestyle Properties
ELS
$11.7B
| $561K | 0.01% |
9,101
+4,969
| +120% | +$306K |
|
532
Arrowhead Research
ARWR
$3.93B
| $559K | 0.01% |
35,359
+5,466
| +18% | +$86.4K |
|
533
Akero Therapeutics
AKRO
$3.59B
| $546K | 0.01% |
10,239
-1,539
| -13% | -$82.1K |
|
534
Madrigal Pharmaceuticals
MDGL
$9.63B
| $545K | 0.01% |
1,801
-477
| -21% | -$144K |
|
535
American Homes 4 Rent
AMH
$12.8B
| $542K | 0.01% |
15,035
+8,231
| +121% | +$297K |
|
536
Albemarle
ALB
$9.24B
| $542K | 0.01% |
8,647
+1,783
| +26% | +$112K |
|
|
PARA
537
DELISTED
Paramount Global Class B
PARA
| $541K | 0.01% |
41,909
+8,921
| +27% | +$115K |
|
538
Scholar Rock
SRRK
$3.14B
| $537K | 0.01% |
+15,153
| New | +$537K |
|
539
Zillow
Z
$20.2B
| $531K | 0.01% |
7,580
+4,149
| +121% | +$291K |
|
540
Arvinas
ARVN
$560M
| $531K | 0.01% |
72,114
+33,799
| +88% | +$249K |
|
541
Viking Therapeutics
VKTX
$2.97B
| $524K | 0.01% |
19,755
+524
| +3% | +$13.9K |
|
542
Annaly Capital Management
NLY
$13.9B
| $519K | 0.01% |
27,576
+15,101
| +121% | +$284K |
|
543
Mirum Pharmaceuticals
MIRM
$3.74B
| $506K | 0.01% |
9,947
-1,485
| -13% | -$75.6K |
|
|
RAL
544
Ralliant Corporation
RAL
$4.78B
| $505K | 0.01% |
+10,421
| New | +$505K |
|
545
Dayforce
DAY
$11B
| $505K | 0.01% |
9,115
+1,789
| +24% | +$99.1K |
|
546
Lamar Advertising Co
LAMR
$12.8B
| $503K | 0.01% |
4,144
+2,249
| +119% | +$273K |
|
547
Omega Healthcare
OHI
$12.6B
| $492K | 0.01% |
13,422
+7,347
| +121% | +$269K |
|
548
Neurocrine Biosciences
NBIX
$13.6B
| $491K | 0.01% |
3,904
| – | – |
|
549
Arcus Biosciences
RCUS
$1.21B
| $486K | 0.01% |
59,662
+44,411
| +291% | +$362K |
|
550
Teva Pharmaceuticals
TEVA
$21.3B
| $484K | 0.01% |
28,861
| – | – |
|